Chinese herbal medicine for Alzheimer’s disease: Clinical evidence and possible mechanism of neurogenesis - Yang, Wen-ting; Zheng, Xia-wei; Chen, Shuang; Shan, Chun-shuo; Xu, Qing-qing; Zhu, Jia-Zhen; Bao, Xiao-Yi; Lin, Yan; Zheng, Guo-qing; Wang, Yan (Biochemical pharmacology, 2017)
Keywords: Alzheimer Disease - drug therapy; Alzheimer Disease - metabolism; Alzheimer Disease - pathology; Dementia; Drugs, Chinese Herbal - pharmacology; Drugs, Chinese Herbal - therapeutic use; Humans; Medicine, Chinese Traditional - methods; Mini-Mental State Examination; Neurogenesis; Neurogenesis - drug effects; Neurogenesis - physiology; Randomized Controlled Trials as Topic - methods; Systematic review; Traditional Chinese medicine; RoB; ITT; Icariin (PubChem CID: 5318997); ADL; CHM; Systematic review; MDA; tid; Aβ; Salvianolic acid A (PubChem CID: 5281793); qd; Nrf 2; PI3K; GSK3; Ginsenoside Rb1 (PubChem CID: 9898279); MD; mg; GRb1; qn; Astragaloside IV (PubChem CID: 13943297); DSM; ml; Glabridin (PubChem CID: 124052); Catalpol (PubChem CID: 91520); Ginsenoside Rg1 (PubChem CID: 441923); AD; ADAS-cog; Tanshinone I (PubChem CID: 114917); NINCDS-ADRDA; nT/nC; SMD; eIF2α; NSCs; MEK; Tetramethylpyrazine (PubChem CID: 14296); NPI-Q; vs; Mini-Mental State Examination; ERK; TCM; Dementia; RCT; NPI; ChEIs; HO-1; Liquiritin (PubChem CID: 503737); PERK; Neurogenesis; CREB; MMSE; PPARg; 8-OHdG; GSH-Px; EMBASE; BDNF; Fig; CI; g; Traditional Chinese medicine; SOD; ICD; FEM; p.o; TrkB; GRg1; NPCs; w; ICR; MPTP; REM; bid